Events
How to Present a CMC Strategy That Gets Funded [WEBINAR]
Join the Biotech CMC Bootcamp preview
Online Webinar / 19th March 2026
2 February 2026
Podcast
Breaking the Death Spiral: How to Rescue Failing CDMO Relationships Before It’s Too Late
“When I walked into the tech transfer, we were a million dollars over budget, six months behind schedule, and struggling to make a single successful batch,” says Amy Gamber. Amy Gamber, Executive Director, Lifecycle Lead at Kyverna Therapeutics, specializes in
9 December 2025
Expert Insight
Robust Analytics for Novel Modalities: Industry Leaders Share Strategies
As cell and gene therapies, RNA-based platforms, and antibody-drug conjugates accelerate toward commercialization, the pharmaceutical industry must develop analytical methods robust enough to characterize increasingly complex therapeutic modalities while remaining flexible enough to evolve with emerging science. PharmaSource asked analytical
3 December 2025
Podcast
Building Investor-Ready CMC Programs: Marta Kijanka’s Strategic Framework for Early-Stage Biotechs
“CDMOs are partners with deep, extensive technical expertise that can be leveraged strategically—not just a restaurant where you pick from a menu.” Marta Kijanka, founder of MK Bioconsultancy, is a strategic project manager and CMC consultant who guides early-stage biotech
20 October 2025
Podcast
Sterile Injectable Manufacturing: The Hidden Complexities Costing Biotech Companies Millions
Carole Delauney warns that sterile injectable manufacturing “is not just fill-finish”—a misconception that can cost biotech companies millions and even derail entire drug development programs. She notes, “This is unfortunately not commonly recognized in the industry, but it is a
6 October 2025
Expert Insight
Why Early CMC Planning Still Fails—and How to Fix It
“CMC success is rarely the product of last-minute fixes. It comes from embedding strategic foresight, regulatory awareness, and cross-functional collaboration from day one.” — Evelien Stalmeijer Evelien Stalmeijer, Chief Cell & Gene Therapy Consultant at eXmoor Pharma, brings deep expertise
2 September 2025